Tag: Vaccines
One-Dose MVA-BN Vaccine Moderately Effective Against Mpox
In a recent study, one dose of modified vaccinia Ankara-Bavarian Nordic vaccine had estimated vaccine effectiveness of 58 percent
Many Americans Wary of Vaccines as Fall Flu, COVID Season Looms: Survey
Fewer Complications at 18 Months Seen With Post-COVID-19 Vaccination Myocarditis
In contrast, post-COVID-19 myocarditis shows outcomes similar to conventional myocarditis
Vaccination Coverage for Teens Similar in 2023 and 2022
Vaccination coverage generally stable for VFC-eligible adolescents during COVID-19 except for decline in those up to date with HPV
Incidence of Mental Illness Up After COVID-19 in Unvaccinated People
Incidence of mental illness lower in vaccinated cohort compared with pre-vaccine availability and unvaccinated cohorts
FDA Approves Updated COVID Shots for Fall
This Week Could Bring FDA Approval of Fall COVID-19 Vaccines
Approval comes much earlier than last year, when autumn shots were announced in mid-September
Vaccines for Children Program Has Increased Coverage, but Gaps Remain
VFC-eligible children have lower coverage for at least one MMR dose, two to three doses of rotavirus, combined seven-vaccine series
Most Patients With MS Have No Risk for Relapse After COVID-19 Vaccination
For patients with high MS activity, small increase in relapse risk seen after booster dose, especially for those not treated
Childhood Vaccinations Have Prevented ~508 Million Lifetime Cases of Illness
Net savings of $540 billion in direct costs and $2.7 trillion in societal costs seen in association with routine childhood vaccinations
